Company: AstraZeneca PLC
Bloomberg ticker: AZN LN
Market cap: US$200,088m
Background: AstraZeneca PLC is a science-led biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory and immunology.
World Class Benchmarking of AstraZeneca
(Click on image to enlarge)
- Profitable Growth rank of 4 was down compared to the prior period’s 3rd rank
- This is above average performance compared to 380 large Health Care companies worldwide
- Profitability rank of 4 was better than its Growth rank of 7
- Profitability rank of 4 was the same compared to the prior period’s 4th rank
- This is above average performance compared to peers
- Growth rank of 7 was down compared to the prior period’s 1st rank
- This is below average performance compared to peers
More By This Author:
Asian Stock: Sinopharm Group
European Stock: Prada SpA
European Stock: Burberry Group
Comments
Log in or sign up to join the conversation.